- Global Pharma News & Resources

Company Directory - Diagnostics

As a health technology platform company, we’re building diverse datasets to unlock scientific discoveries as well as improve diagnostic and treatment outcomes within Africa and the global community.
BARD1 Life Sciences Ltd (ASX:BD1) (BARD1 or the Company) is a leading Australian-based medical diagnostics company with an innovative portfolio of diagnostic technologies and products.
BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest independent producer of immuno-diagnostics reagents. Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies.
Biotype develops, produces and sells molecular diagnostic kits for the detection and quantification of RNA and DNA markers. The assays support diagnosis and therapy in the areas of oncology, hemato-oncology, dermatology and forensics.
Circassia is a dedicated diagnostics and monitoring company focused on respiratory disease. Our market-leading NIOX® products are used by physicians around the world to help improve asthma diagnosis and management, and we support our customers through our dedicated teams globally.
Cognomie provides ground-breaking online Executive coaching and building Mental Fitness to optimise performance in organisations around the world.
At Cunesoft we provide intelligent software for regulatory data management to the Life Sciences Industry, delivered as Software as a Service (SaaS). Our customers benefit from process automation combined with compliant document, data and submission management. Our innovative technologies include leading edge machine learning algorithms with ready-to-use document data mining and data extraction solutions that can result in ROI’s of 12 months or less. And everything we do is supported by our global team 100% focused on client satisfaction and user happiness.
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. Founded in 2017, our headquarters is located in San Diego, California, with additional operations located in the San Francisco Bay area.
GovGrant helps pharmaceutical firms who undertake research & development reduce their expenses by claiming tax credits through HMRC schemes.
We work to find cancer precisely, and fast. With machine learning (ML) and artificial intelligence (AI) methods, combined with an MRI scan, we aim to make cancer screening accurate, accessible, cost-effective, and quick.
Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory diseases and other conditions. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine.
TIB Molbiol is a medium-sized biotech company who has supplied the global market for over 30 years with reagents for research and medical diagnostics. We are known for our innovation, product quality, design and time to market.
Using protein biomarkers, UROQUANT will revolutionise diagnostics. The first product, UROQUANT BC for diagnosing bladder cancer directly from urine will be established as novel gold standard for routine cancer patient care.
Zhejiang Kangte Biotechnology Co., Ltd. was established in 2001. It is a national high-tech enterprise integrating R&D, production and sales of in vitro diagnostic reagents. Professional IVD test kit manufacturer and company